Company Filing History:
Years Active: 2000-2004
Title: Inventor Tammy Lawrence: Pioneering Advances in Cancer Genetics
Introduction
Tammy Lawrence, an accomplished inventor based in Laurel, MD, has significantly contributed to the field of genetics, particularly in understanding cancer susceptibility. With three patents to her name, her innovative work focuses on the BRCA1 gene, providing crucial insights into genetic mutations linked to breast and ovarian cancer.
Latest Patents
One of Tammy’s key inventions is the coding sequence haplotype of the human BRCA1 gene. This invention is directed towards isolated coding sequences and the respective protein sequences they produce. The invention provides the coding sequence for the BRCA1(omi4) gene and its protein sequence, which can be used to identify individuals with heightened genetic susceptibility to breast or ovarian cancer due to inherited mutations in their BRCA1 gene. Additionally, the invention relates to methods of gene therapy utilizing the isolated BRCA1(omi4) coding sequence and protein replacement therapy involving the BRCA1(omi4) protein.
Another significant patent pertains to the identification of cancer susceptibility mutations within the BRCA1 gene. Tammy discovered new mutations located at specific nucleotide positions of the BRCA1 sequence. Her process for identifying these sequence variations involves allele-specific sequence-based assays, enabling efficient and accurate detection of mutations in BRCA1 gene samples.
Career Highlights
Tammy Lawrence has worked with notable companies such as Oncormed, Inc. and Gene Logic, Inc., where she applied her expertise in genetics to advance their research initiatives. Her work has been pivotal in laying the groundwork for innovations that can have a substantial impact on cancer diagnostics and treatment.
Collaborations
Throughout her career, Tammy has collaborated with esteemed colleagues, including Sheri J. Olson and Tracy Staton Angelly. These partnerships have fostered an environment of innovation and have contributed to the successful development of her patents, highlighting the cooperative spirit prevalent in the scientific community.
Conclusion
Tammy Lawrence exemplifies the role of an innovative inventor dedicated to advancing our understanding of genetic factors associated with cancer. With her groundbreaking patents focusing on the BRCA1 gene, she continues to push the boundaries of genetic research, striving for improved diagnostic and therapeutic options for individuals at risk of breast and ovarian cancer. Her contributions not only enhance scientific knowledge but also hold the potential for life-saving advancements in the field of healthcare.